Time course of α4-integrin receptor desaturation and disease activity return after natalizumab cessation: A prospective assessment from the TOFINGO study

Authors
Category Primary study
ConferenceMultiple Sclerosis
Year 2015
This article has no abstract
Epistemonikos ID: 95951048e651e656a0eb11e86addd5323246c75f
First added on: Apr 30, 2026